Skip to content

INO - INOVIO PHARMACEUTICALS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Inovio Pharmaceuticals Inc

INO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

INOInovio Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.98
52-wk low: $0.56
Prev close: $1.71
Mkt cap: $134.4M
Fwd P/E: 16.6x
Beta: 1.51

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$14.9M

DS
D.E. Shaw
Q2 2026 13F
$1.5M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 72.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 16.58
Market cap: $134M

Valuation

P/S961.51
P/B28.39

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: INO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $134.42M
Beta: 1.51

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

961.5x

P/B

28.4x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-409.9%

$1.4M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$876K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for INO

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.07+72.0%

-$0.25 expected

Next report

What the street expects next

EPS expected

-$0.20

-$0.20 to -$0.19

Revenue expected

$0.00

3 analysts

Last 30 days

2up0down

Analysts raising estimates

Estimate drift

+0.05

Change in 30 days

-409.9%

ROA-84.2%

Growth

Beta1.51